Industry / Belgium
Belgian Industry Association Defends Pharmaceutical Spending
July 2008 | Industry NewsBelgium's drug industry association, pharma.be, has defended the price of medicines in the country following local reports suggesting the market is over-priced. Pharma.be also claims that Organisation for Economic Co-Operation and Development (OECD) figures for pharmaceutical expenditure in Belgium that portray the country as expensive are not right.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
